ArticleFrontiers in oncology2026
Malignant adenomyoepithelioma of the breast with axillary metastasis: a case report in a patient undergoing
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant Adenomyoepithelioma (MAME) is a very rare tumor derived from the mixed proliferation of glandular epithelium and muscular epithelium. It has a wide spectrum of histomorphology, a high risk of local recurrence and distant metastasis, and there are few reports of axillary lymph node metastasis. This article reports a case of a breast nodule that had persisted for over 20 years and progressively enlarged during targeted therapy for pulmonary adenocarcinoma. It was eventually diagnosed as malignant adenomyoepithelioma of the breast, and axillary lymph node metastasis was later found. The sensitivity of preoperative imaging is low, and the diagnosis relies on postoperative pathology and immunohistochemistry. The efficacy of adjuvant therapy (chemotherapy or radiotherapy) is uncertain and mostly based on individual experience. Therefore, this article, in combination with previous research, comprehensively analyzes the clinical and pathological characteristics, treatment methods, and prognosis of this disease to enhance the understanding of this tumor and optimize its management strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.